Cargando…

Circulating Liver-Specific miR-122 as a Novel Potential Biomarker for Diagnosis of Cholestatic Liver Injury

BACKGROUND: Circulating microRNA-122 (miR-122) has been increasingly reported to be a potential biomarker for drug-, viral-, alcohol- and chemical-induced liver injury. The present study was initiated to determine the potential of circulating miR-122 as a biomarker for cholestatic liver injury. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shifeng, Huang, Danni, Wang, Pu, Chen, Ping, Yang, Ju, Cao, Liping, Zhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785475/ https://www.ncbi.nlm.nih.gov/pubmed/24086271 http://dx.doi.org/10.1371/journal.pone.0073133

Ejemplares similares

Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease
por: Goldschmidt, Imeke, et al.
Publicado: (2016)

Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals
por: Murray, Daniel D., et al.
Publicado: (2017)

MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability
por: Singh, Sandeep, et al.
Publicado: (2020)

Circulating microRNAs (miR‐16, miR‐22, miR‐122) expression and early diagnosis of hepatocellular carcinoma
por: Fang, Yujia, et al.
Publicado: (2022)

Circulating miR-122-5p, miR-92a-3p, and miR-18a-5p as Potential Biomarkers in Human Liver Transplantation Follow-Up
por: Morsiani, Cristina, et al.
Publicado: (2023)

Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease
por: Salvoza, Noel C., et al.
Publicado: (2016)

Kinetics of miR-122 Expression in the Liver during Acute HCV Infection
por: Choi, Youkyung, et al.
Publicado: (2013)

Potential relative quantities of miR-122 and miR-150 to differentiate hepatocellular carcinoma from liver cirrhosis
por: Gumilas, Nur Signa Aini, et al.
Publicado: (2022)

Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
por: Nemecz, Miruna, et al.
Publicado: (2023)

Serum exosomal miR-122 as a potential diagnostic and prognostic biomarker of colorectal cancer with liver metastasis
por: Sun, Li, et al.
Publicado: (2020)

Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
por: Amr, Khalda S., et al.
Publicado: (2017)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

ADAR2-Mediated Editing of miR-214 and miR-122 Precursor and Antisense RNA Transcripts in Liver Cancers
por: Liu, Wan-Hsin, et al.
Publicado: (2013)

Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome
por: Li, Xiangdong, et al.
Publicado: (2015)

Hepatitis C virus genetics affects miR-122 requirements and response to miR-122 inhibitors
por: Israelow, Benjamin, et al.
Publicado: (2014)

The diagnostic role of miR-122 in drug-induced liver injury: A systematic review and meta-analysis
por: Liu, Yiqi, et al.
Publicado: (2018)

Analysis of association between circulating miR-122 and histopathological features of nonalcoholic fatty liver disease in patients free of hepatocellular carcinoma
por: Akuta, Norio, et al.
Publicado: (2016)

miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
por: Ivo D’Urso, Pietro, et al.
Publicado: (2015)

miR-155 and miR-122 Expression of Spermatozoa in Obese Subjects
por: López, Paulina, et al.
Publicado: (2018)

miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2016)

The Accelerated Progression of Atherosclerosis Correlates with Decreased miR-33a and miR-21 and Increased miR-122 and miR-3064-5p in Circulation and the Liver of ApoE-/- Mice with Streptozocin (STZ)-Induced Type 2 Diabetes
por: Luo, Hui-Yu, et al.
Publicado: (2022)

Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer
por: Mazza, Tommaso, et al.
Publicado: (2020)

Association of circulating exosomal miR-122 levels with BAT activity in healthy humans
por: Okamatsu-Ogura, Yuko, et al.
Publicado: (2019)

The effects of multifunctional MiR-122-loaded graphene-gold composites on drug-resistant liver cancer
por: Yuan, Yi, et al.
Publicado: (2015)

Role of B Cell Lymphoma 2 in the Regulation of Liver Fibrosis in miR-122 Knockout Mice
por: Teng, Kun-Yu, et al.
Publicado: (2020)

Silibinin improves nonalcoholic fatty liver by regulating the expression of miR-122: An in vitro and in vivo study
por: Yang, Liying, et al.
Publicado: (2021)

Validation in an Independent Cohort of MiR-122, MiR-1271, and MiR-15b as Urinary Biomarkers for the Potential Early Diagnosis of Clear Cell Renal Cell Carcinoma
por: Cochetti, Giovanni, et al.
Publicado: (2022)

Circulating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the Liver
por: Ahmed, Emad K., et al.
Publicado: (2019)

Microfluidic system for near-patient extraction and detection of miR-122 microRNA biomarker for drug-induced liver injury diagnostics
por: Kersaudy-Kerhoas, Maïwenn, et al.
Publicado: (2022)

Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
por: Du, Mulong, et al.
Publicado: (2015)

Detection of increased serum miR-122-5p and miR-455-3p levels before the clinical diagnosis of liver cancer in people with type 2 diabetes
por: Lee, Heung Man, et al.
Publicado: (2021)

Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
por: Loosen, Sven H., et al.
Publicado: (2019)

miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling
por: Sendi, Hossein, et al.
Publicado: (2018)

Potentials of the elevated circulating miR-185 level as a biomarker for early diagnosis of HBV-related liver fibrosis
por: Li, Bin-bin, et al.
Publicado: (2016)

Variance component analysis of circulating miR-122 in serum from healthy human volunteers
por: Vogt, Jennifer, et al.
Publicado: (2019)

Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis
por: Yin, Shenyi, et al.
Publicado: (2016)

Characterization of miR-122-independent propagation of HCV
por: Ono, Chikako, et al.
Publicado: (2017)

Regulation of hepatic glutamine metabolism by miR-122
por: Sengupta, Dipanwita, et al.
Publicado: (2020)

Bioinformatics analysis of the common targets of miR-223-3p, miR-122-5p, and miR-93-5p in polycystic ovarian syndrome
por: Zou, Liping, et al.
Publicado: (2023)

Diagnostic potential and pathogenic performance of circulating miR-146b, miR-194, and miR-214 in liver fibrosis
por: Aghajanzadeh, Taha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_oqrtgkoro1om9e2p7itmvdrneb